WSJ's Paul Gigot's Biggest Miss Of 2009: Big Pharma Is Going To Have Some Price Controls

From Fox News's Journal Editorial Report, The Wall Street Journal's Paul Gigot's biggest miss of 2009 is big pharma cutting a deal with the White Hous
up

From Fox News's Journal Editorial Report, The Wall Street Journal's Paul Gigot's biggest miss of 2009 is big pharma cutting a deal with the White House on the health care bill because heaven forbid they might end up with some price controls put on them. Nothing like watching these compassionate conservatives looking out for the poor little old pharmaceutical industry is there?

Gigot: My miss is for the big drug company CEO’s, those who got in bed with the Obama administration on health care reform. They thought they’d get a deal, save themselves from spending too much money, but in the end they helped to make this pass by spending tens of millions on advertising and when it does pass, price controls are in their future. Just goes to show you that big business, if you’re relying on them to help you and help the free enterprise system, they’ll always let you down.

If they were going to have any meaningful price controls, they'd have passed Sen. Dorgan's amendment.

About Heather

Comments

We welcome relevant, respectful comments. Please refer to our Terms of Service for information on our posting policy.